Sodium Stibogluconate
Paul G. Auwaerter, M.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Sodium stibogluconate is not FDA-approved or commercially available in the U.S.
- Pentostam was discontinued by its manufacturer, and the CDC subsequently closed its SSG IND protocol after existing supplies expired.
- SSG may still be available in some countries outside the U.S.
- If pentavalent antimonial therapy is considered necessary in the U.S., meglumine antimoniate (Glucantime) may be obtained from Sanofi under an individual-patient FDA IND/expanded-access protocol; expert consultation is advised.
- For U.S. VL, liposomal amphotericin B is generally preferred.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2026 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.